Announcements Trials

Browse Landscape

Phase

Phase 2 13 Phase 1/2 5 Phase 3 3 Phase NA 2 Phase 4 1 Phase 2/3 1

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1

Interventions

Cisplatin 10 Gemcitabine 7 Fluorouracil 7 Carboplatin 7 Capecitabine 7 venetoclax 5 Oxaliplatin 5 Cyclophosphamide 4 sintilimab 3 Radiotherapy 3 Neoadjuvant Therapy 3 Dexamethasone 3 Bevacizumab 3 Azacitidine 3 130-nm albumin-bound paclitaxel 3 trametinib 2 regorafenib 2 pembrolizumab 2 nimotuzumab 2 fludarabine 2 disitamab vedotin 2 daratumumab 2 dabrafenib 2 camrelizumab 2 blinatumomab 2 apatinib 2 Trastuzumab 2 Temozolomide 2 Radiotherapy, Intensity-Modulated 2 Radiation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Not yet recruiting × HMPL-013 × Clear all

NCT06443671 2024-06-05

PKUCH-R09

Peking University Cancer Hospital & Institute

Phase 2/3 Not yet recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡